CRISPR Pioneers Launch Helios: 1,000+ Protein Biomarkers From a Drop of Blood, Backed by YC

omarabudayyeh · x · 2026-11-19

Helios, a Y Combinator-backed biotech startup founded by CRISPR pioneers from Feng Zhang's lab, launched a longevity product measuring 1,000+ protein biomarkers from a drop of blood. Users self-collect blood at home with a needle-free device, and a Helios AI agent explains results, flags risks, and offers personalized guidance. The team's prior startups raised $400M; investors include Y Combinator and Formation VC.

Original post →

More from Companies & People

Companies & People channel →